Table of Contents
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2
List of Figures 8
2 Introduction 10
2.1 What Is This Report About?
10
3 Definitions of Markets Covered in the Report 11
3.1 Diabetes Care
Devices 11
3.2 Glucose Monitoring Devices 11
3.2.1 Blood Glucose
Meters 11
3.2.2 Blood Glucose Strips 11
3.3 Insulin Delivery 11
3.3.1 Insulin Pens 11
3.3.2 Insulin Syringes 12
3.3.3 Insulin Pumps
12
3.3.4 Traditional Insulin Pump Accessories 12
4 Healthcare Sector
Review 13
4.1 Healthcare Sector Review 13
4.2 Healthcare Expenditure
13
4.3 Healthcare Infrastructure 14
4.3.1 Healthcare Personnel Data
15
4.3.2 Healthcare Facilities Data 16
4.4 Healthcare Policy 17
5
Regulation System 18
5.1 Medical Equipment Approval Process 18
5.1.1
Classification 19
5.1.2 Conformity Assessment Process 27
5.1.3
Registration Fee 31
5.1.4 Registration Period 31
5.2 Post Market
Surveillance (PMS) 32
6 Pricing and Reimbursement 33
6.1 Pricing and
Reimbursement Policies 33
7 Distribution Structure 34
7.1 France
Medical Equipment Distribution Structure 34
8 Diabetes Care Devices In
France 35
8.1 Diabetes Care Devices, Cross Country Comparison, Revenue ($
mn), 2000-2015 35
8.2 Diabetes Care Devices, France, Overall Revenue ($
mn), 2000-2015 36
8.3 Diabetes Care Devices, France, Category Volume
(Units), 2000-2015 40
8.4 Diabetes Care Devices, France, Company Share
(2007-2008) 43
9 Glucose Monitoring In France 44
9.1 Glucose
Monitoring Overall Revenue (2000-2015) 44
9.1.1 Blood Glucose Meters
Overall Revenue (2000-2015) 46
9.2 Glucose Monitoring Overall Volume
(2000-2015) 48
9.2.1 Blood Glucose Meters Overall Volume (2000-2015)
50
9.3 Glucose Monitoring Average Price (2000-2015) 52
9.4 Glucose
Monitoring Distribution Share (2007-2008) 53
9.5 Glucose Monitoring,
France, Company Share (2007-2008) 54
10 Insulin Delivery In France 55
10.1 Insulin Delivery Overall Revenue (2000-2015) 55
10.1.1 Insulin Pens
Overall Revenue (2000-2015) 57
10.2 Insulin Delivery Overall Volume
(2000-2015) 59
10.2.1 Insulin Pens Overall Volume (2000-2015) 60
10.3
Insulin Delivery Average Price (2000-2015) 62
10.4 Insulin Delivery
Distribution Share (2007-2008) 63
10.5 Insulin Delivery, France, Company
Share (2007-2008) 64
11 Overview of Key Companies in France Diabetes Care
Devices Market 65
11.1 F. Hoffmann-La Roche Ltd. 65
11.1.1 Company
Overview 65
11.1.2 Value Chain Analysis 66
11.1.3 F. Hoffmann-La Roche
Ltd Pipeline Products 68
11.2 LifeScan, Inc. 69
11.2.1 Company
Overview 69
11.2.2 LifeScan, Inc. Pipeline Products 69
11.3 Abbott
Laboratories 71
11.3.1 Company Overview 71
11.3.2 Value Chain Analysis
72
11.3.3 Abbott Laboratories Pipeline Products 74
11.4 Bayer
HealthCare AG 76
11.4.1 Company Overview 76
11.4.2 Value Chain
Analysis 77
11.4.3 Bayer HealthCare AG Pipeline Products 79
11.5 Novo
Nordisk A/S 80
11.5.1 Company Overview 80
11.5.2 Novo Nordisk A/S
Pipeline Products 80
11.6 Medtronic, Inc. 82
11.6.1 Company Overview
82
11.6.2 Value Chain Analysis 83
11.6.3 Medtronic, Inc. Pipeline
Products 85
11.7 Becton, Dickinson and Company 93
11.7.1 Company
Overview 93
11.7.2 Value Chain Analysis 93
11.8 Eli Lilly and Company
95
11.8.1 Company Overview 95
11.8.2 Value Chain Analysis 95
11.8.3 Eli Lilly and Company Pipeline Products 98
11.9 ARKRAY, Inc. 99
11.9.1 Company Overview 99
11.9.2 ARKRAY, Inc. Pipeline Products 99
11.10 Terumo Corporation 101
11.10.1 Company Overview 101
11.10.2
Value Chain Analysis 101
11.11 Animas Corporation 103
11.11.1 Company
Overview 103
11.12 Sanofi-Aventis 103
11.12.1 Company Overview 103
11.13 Smiths Medical 104
11.13.1 Company Overview 104
11.13.2 Value
Chain Analysis 105
12 Recent Developments 107
12.1 Strategy And
Business Planning 107
12.1.1 May 18, 2009: Sanofi-aventis, DND Collaborate
For Sleeping Sickness Drug 107
13 Appendix 108
13.1 Global Markets
Direct Research Methodology 108
13.2 Coverage 109
13.3 Secondary
Research 109
13.4 Primary Research 110
13.5 Models 110
13.6
Forecasts 111
13.7 Expert Panel Validation 111
13.8 Currency
Conversion 112
13.9 Contact Us 113
13.10 Disclaimer 113
1.1 List of Tables
Table 1: Number of Doctors by Specialty in France,
2003-2007 15
Table 2: Number of Hospital Wards by Specialty in France,
2003-2007 16
Table 3: Diabetes Care Devices, Cross Country
Comparison, Revenue ($ mn), 2000-2015 35
Table 4: Diabetes Care
Devices, France, Overall Revenue ($ mn), 2000-2015 36
Table 5: Diabetes
Care Devices, France, Cross-Category Analysis, 2000-2015 37
Table 6:
Diabetes Care Devices, France, Overall Revenue ($ mn), Historic, 2000-2008
38
Table 7: Diabetes Care Devices, France, Overall Revenue ($ mn),
Forecast, 2008-2015 39
Table 8: Diabetes Care Devices, France,
Category Volume (Units), 2000-2015 40
Table 9: Diabetes Care Devices,
France, Category Volume (Units), Historic, 2000-2008 41
Table 10:
Diabetes Care Devices, France, Category Volume (Units), Forecast, 2008-2015
42
Table 11: Diabetes Care Devices, France, Company Share by Revenue
($ mn), 2007-2008 43
Table 12: Glucose Monitoring, France, Revenue ($
mn) by Segment, Historic, 2000-2008 44
Table 13: Glucose Monitoring,
France, Revenue ($ mn) by Segment, Forecast, 2008-2015 45
Table 14:
Blood Glucose Meters, France, Revenue ($ mn) by Sub-Segment, Historic,
2000-2008 46
Table 15: Blood Glucose Meters, France, Revenue ($ mn)
by Sub-Segment, Forecast, 2008-2015 47
Table 16: Glucose Monitoring,
France, Volume (Units) by Segment, Historic, 2000-2008 48
Table 17:
Glucose Monitoring, France, Volume (Units) by Segment, Forecast, 2008-2015
49
Table 18: Blood Glucose Meters, France, Volume (Units) by
Sub-Segment, Historic, 2000-2008 50
Table 19: Blood Glucose Meters,
France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 51
Table 20:
Glucose Monitoring, France, Average Price ($), Historic, 2000-2008 52
Table 21: Glucose Monitoring, France, Average Price ($), Forecast,
2008-2015 52
Table 22: Glucose Monitoring, France, Distribution Share
by Revenue ($mn), 2007-2008 53
Table 23: Glucose Monitoring, France,
Company Share by Revenue ($ mn), 2007-2008 54
Table 24: Insulin
Delivery, France, Revenue ($ mn) by Segment, Historic, 2000-2008 55
Table
25: Insulin Delivery, France, Revenue ($ mn) by Segment, Forecast,
2008-2015 56
Table 26: Insulin Pens, France, Revenue ($ mn) by
Sub-Segment, Historic, 2000-2008 57
Table 27: Insulin Pens, France,
Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 58
Table 28:
Insulin Delivery, France, Volume (Units) by Segment, Historic, 2000-2008
59
Table 29: Insulin Delivery, France, Volume (Units) by Segment,
Forecast, 2008-2015 59
Table 30: Insulin Pens, France, Volume (Units)
by Sub-Segment, Historic, 2000-2008 60
Table 31: Insulin Pens,
France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 61
Table 32:
Insulin Delivery, France, Average Price ($), Historic, 2000-2008 62
Table 33: Insulin Delivery, France, Average Price ($), Forecast,
2008-2015 62
Table 34: Insulin Delivery, France, Distribution Share
by Revenue ($mn), 2007-2008 63
Table 35: Insulin Delivery, France,
Company Share by Revenue ($ mn), 2007-2008 64
Table 36: F.
Hoffmann-La Roche Ltd Pipeline Products by Equipment Type 68
Table 37:
F. Hoffmann-La Roche Ltd Pipeline Products by Development Stage 68
Table
38: F. Hoffmann-La Roche Ltd Pipeline Products by Therapy Area 68
Table 39: LifeScan, Inc. Pipeline Products by Equipment Type 69
Table
40: LifeScan, Inc. Pipeline Products by Development Stage 69
Table
41: LifeScan, Inc. Pipeline Products by Therapy Area 69
Table 42:
LifeScan, Inc. Pipeline Products by Clinical Trials 70
Table 43:
LifeScan, Inc. Pipeline Products by News Summary 70
Table 44: Abbott
Laboratories Pipeline Products by Equipment Type 74
Table 45: Abbott
Laboratories Pipeline Products by Development Stage 74
Table 46:
Abbott Laboratories Pipeline Products by Therapy Area 74
Table 47:
Abbott Laboratories Pipeline Products by Clinical Trials 75
Table 48:
Abbott Laboratories Pipeline Products by News Summary 75
Table 49:
Bayer HealthCare AG Pipeline Products by Equipment Type 79
Table 50:
Bayer HealthCare AG Pipeline Products by Development Stage 79
Table 51:
Bayer HealthCare AG Pipeline Products by Therapy Area 79
Table 52:
Bayer HealthCare AG Pipeline Products by News Summary 79
Table 53:
Novo Nordisk A/S Pipeline Products by Equipment Type 80
Table 54:
Novo Nordisk A/S Pipeline Products By Development Stage 80
Table 55:
Novo Nordisk A/S Pipeline Products By Therapy Area 81
Table 56: Novo
Nordisk A/S Pipeline Products By Clinical Trials 81
Table 57:
Medtronic, Inc. Pipeline Products by Equipment Type 85
Table 58:
Medtronic, Inc. Pipeline Products By Development Stage 87
Table 59:
Medtronic, Inc. Pipeline Products By Therapy Area 89
Table 60:
Medtronic, Inc. Pipeline Products By Clinical Trials 91
Table 61:
Medtronic, Inc. Pipeline Products By News Summary 92
Table 62: Eli
Lilly and Company Pipeline Products by Equipment Type 98
Table 63:
Eli Lilly and Company Pipeline Products by Development Stage 98
Table 64:
Eli Lilly and Company Pipeline Products by Therapy Area 98
Table 65:
Eli Lilly and Company Pipeline Products by Clinical Trials 98
Table 66:
Eli Lilly and Company Pipeline Products by News Summary 98
Table 67:
ARKRAY, Inc. Pipeline Products by Equipment Type 99
Table 68:
ARKRAY, Inc. Pipeline Products by Development Stage 99
Table 69:
ARKRAY, Inc. Pipeline Products by Clinical Trials 100
Table 70:
ARKRAY, Inc. Pipeline Products by News Summary 100
Table 71: USD to
Local Currency, Average Exchange Rate 2008 112
1.2 List of
Figures
Figure 1: Total Healthcare Expenditure in France, 2000 - 2006
14
Figure 2: Flowchart for Classification of Non-invasive Devices in
France, 2007 20
Figure 3: Flowchart for Classification of Invasive Devices
in France, 2007 21
Figure 4: Flowchart for Classification of Invasive
Devices in France, 2007 22
Figure 5: Flowchart for Classification of
Invasive Devices in France, 2007 23
Figure 6: Flowchart for Classification
of Invasive Devices in France, 2007 24
Figure 7: Flowchart for
Classification of Active Devices in France, 2007 25
Figure 8: Flowchart
for Classification of Active Devices in France, 2007 26
Figure 9:
Flowchart for Classification of Devices except Non-invasive, Invasive and
Active Devices in France, 2007 27
Figure 10: Conformity Assessment of
Class-I Medical Devices in France, 2007 28
Figure 11: Conformity
Assessment of Class-IIa Medical Devices in France, 2007 29
Figure 12:
Conformity Assessment of Class-IIb Medical Devices in France, 2007 30
Figure 13: Conformity Assessment of Class-III Medical Devices in France, 2007
31
Figure 14: Medical Equipment Distribution Structure in France, 2007
34
Figure 15: Diabetes Care Devices, Cross Country Comparison,
Revenue ($ mn), 2000-2015 35
Figure 16: Diabetes Care Devices,
France, Overall Revenue ($ mn), 2000-2015 36
Figure 17: Diabetes Care
Devices, France, Cross-Category Analysis, 2000-2015 37
Figure 18:
Diabetes Care Devices, France, Overall Revenue ($ mn), Historic, 2000-2008
38
Figure 19: Diabetes Care Devices, France, Overall Revenue ($ mn),
Forecast, 2008-2015 39
Figure 20: Diabetes Care Devices, France,
Category Volume (Units), 2000-2015 40
Figure 21: Diabetes Care
Devices, France, Category Volume (Units), Historic, 2000-2008 41
Figure
22: Diabetes Care Devices, France, Category Volume (Units), Forecast,
2008-2015 42
Figure 23: Diabetes Care Devices, France, Company Share
(%), 2008 43
Figure 24: Glucose Monitoring, France, Revenue ($ mn) by
Segment, Historic, 2000-2008 44
Figure 25: Glucose Monitoring,
France, Revenue ($ mn) by Segment, Forecast, 2008-2015 45
Figure 26:
Blood Glucose Meters, France, Revenue ($ mn) by Sub-Segment, Historic,
2000-2008 46
Figure 27: Blood Glucose Meters, France, Revenue ($ mn)
by Sub-Segment, Forecast, 2008-2015 47
Figure 28: Glucose Monitoring,
France, Volume (Units) by Segment, Historic, 2000-2008 48
Figure 29:
Glucose Monitoring, France, Volume (Units) by Segment, Forecast, 2008-2015
49
Figure 30: Blood Glucose Meters, France, Volume (Units) by
Sub-Segment, Historic, 2000-2008 50
Figure 31: Blood Glucose Meters,
France, Volume (Units) by Sub-Segment, Forecast, 2008-2015 51
Figure 32:
Glucose Monitoring, France, Company Share (%), 2008 54
Figure 33:
Insulin Delivery, France, Revenue ($ mn) by Segment, Historic, 2000-2008
55
Figure 34: Insulin Delivery, France, Revenue ($ mn) by Segment,
Forecast, 2008-2015 56
Figure 35: Insulin Pens, France, Revenue ($
mn) by Sub-Segment, Historic, 2000-2008 57
Figure 36: Insulin Pens,
France, Revenue ($ mn) by Sub-Segment, Forecast, 2008-2015 58
Figure 37:
Insulin Pens, France, Volume (Units) by Sub-Segment, Historic, 2000-2008
60
Figure 38: Insulin Pens, France, Volume (Units) by Sub-Segment,
Forecast, 2008-2015 61
Figure 39: Insulin Delivery, France, Company
Share (%), 2008 64
Figure 40: F. Hoffmann-La Roche Ltd Value Chain
Analysis 66
Figure 41: Abbott Laboratories Value Chain Analysis
72
Figure 42: Bayer HealthCare AG Value Chain Analysis 77
Figure
43: Medtronic, Inc. Value Chain Analysis 83
Figure 44: Becton,
Dickinson and Company Value Chain Analysis 93
Figure 45: Eli Lilly
and Company Value Chain Analysis 95
Figure 46: Terumo Corporation
Value Chain Analysis 101
Figure 47: Smiths Medical Value Chain
Analysis 105
Figure 48: Global Markets Direct Methodology 108
|
Related Report
|
View Cart
